Your browser doesn't support javascript.
loading
A Clinical Prognostic Score to Predict Survival of Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Receiving First-Line Chemotherapy: A Retrospective Analysis.
Gong, Jing; Xu, Ling; Li, Zhi; Hu, Xuejun; Liu, Jing; Teng, Yuee; Jin, Bo; Zhao, Mingfang; Shi, Jing; Guo, Tianshu; Shi, Xiaonan; Cheng, Yu; Liu, Yunpeng; Qu, Xiujuan.
  • Gong J; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Xu L; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Li Z; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Hu X; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Liu J; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Teng Y; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Jin B; Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Zhao M; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Shi J; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Guo T; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Shi X; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Cheng Y; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Liu Y; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
  • Qu X; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Med Sci Monit ; 24: 8264-8271, 2018 Nov 17.
Article en En | MEDLINE | ID: mdl-30446633
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article